PriceSensitive

Aleafia Health (TSX:AH) completes TSX review and enters fifth province

Cannabis, Health Care, Market News
TSX:AH
28 November 2022 15:30 (EDT)
Aleafia Health - CEO, Tricia Symmes

Source: Canadian Business

Aleafia Health (AH) has completed the TSX delisting review and has satisfied the Toronto Stock Exchange’s requirements for continued listing.

Aleafia Health will continue to trade on the TSX without further review at this time.

Aleafia Health CEO Tricia Symmes commented on the news.

“We are very pleased that the TSX has completed its five-month-long review process, and the company is no longer being assessed for potential delisting. Over that time period, Aleafia has demonstrated performance in its key financial metrics. It is the result of disciplined work maintaining scalable growth and profitable practices in all areas of business, driving toward our core goals.”

CFO Matt Sale added,

“Driving revenue growth across multiple channels, tightening our expense profile, and building off the success of our flagship brand, Divvy, Aleafia Health remains focused on becoming a top 10 Licensed Producer in the Canadian cannabis landscape. We are excited to continue offering shareholders and consumers a house of brands that shows maintained growth and promise.”

The company has continued its strategic plan to expand adult-use domestic sales and market share, adding Manitoba as its fifth provincial distribution region, enabling Divvy and the rest of the portfolio to reach over 70 per cent of the Canadian population.

The company recently launched a portfolio of twelve products, primarily Divvy, in time for the holiday season.

Aleafia Health owns three licensed cannabis production facilities. It operates a strategically located distribution centre in the province of Ontario, including the first large-scale, legal outdoor cultivation facility in Canadian history.

Aleafia Health Inc. (AH) is up 7.14 per cent on the day, trading at C$0.075 per share at 3 pm ET.


Related News